Device Trial Radar · NCT07286201
Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)
Last checked: Nov 19, 2026Latest source record: Jun 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
110
Planned (sponsor's estimate)
Start
Mar 19, 2026
Primary completion
Mar 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Polyganics BVNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- NAMSA
- First posted
- Dec 16, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the safety and effectiveness of OCEAN as an adjunct aid in wound healing after nasal/sinus surgery and to demonstrate that OCEAN is non-inferior compared to a steroid-eluting sinus stent.
Conditions
- Chronic Rhinosinusitis (CRS)
- Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Interventions
OCEANDevice
Biodegradable nasal dressing applied after sinus/nasal surgery
Steroid-eluting sinus stentDevice
Applied after sinus/nasal surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Serious Adverse EventsTime frame: Up to Day 25
- Endoscopic AssessmentTime frame: Day 25
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Colorado ENT & Allergy
Colorado Springs, Colorado
Emory University
Atlanta, Georgia
University of Illinois at Chicago
Chicago, Illinois
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.